| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA627287 | A | Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat | Rattus norvegicus | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 2. | ALA627288 | A | Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog | Canis lupus familiaris | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 3. | ALA632076 | A | Oral bioavailability in dog | Canis lupus familiaris | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 4. | ALA632079 | A | Oral bioavailability in rat | Rattus norvegicus | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 5. | ALA633751 | A | Tested for pharmacokinetic parameter to calculate the steady-state volume of distributio at a dosage of 12 mg/kg in rat | Rattus norvegicus | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 6. | ALA633752 | A | Tested for pharmacokinetic parameter to calculate the steady-state volume of distributio at a dosage of 2.5 mg/kg in dog | Canis lupus familiaris | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 7. | ALA634837 | A | Tested for pharmacokinetic parameter to calculate the half life period at a dosage of 12 mg/kg in rat | Rattus norvegicus | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 8. | ALA634838 | A | Tested for pharmacokinetic parameter to calculate the half life period at a dosage of 2.5 mg/kg in dog | Canis lupus familiaris | 1 | ALA1127342 | organism-based format | Scientific Literature | |
| 9. | ALA653502 | B | Tested for the inhibitory activity against human aspartyl protease (Beta-secretase), gastricin at 10 uM concentration | Homo sapiens | 1 | ALA1127342 | single protein format | Scientific Literature | |
| 10. | ALA658679 | B | Tested for the inhibitory activity against human aspartyl protease, cathepsin D at 10 uM concentration | 1 | ALA1127342 | single protein format | Scientific Literature | ||
| 11. | ALA661875 | B | Tested for the inhibitory activity against human aspartyl protease, cathepsin E at 10 uM concentration | 1 | ALA1127342 | single protein format | Scientific Literature | ||
| 12. | ALA684601 | F | Tested for the antiviral activity against HIV-1 IIIB-infected H9 cells | Homo sapiens | 1 | ALA1127342 | cell-based format | Scientific Literature | |
| 13. | ALA715317 | F | Tested for the antiviral activity against HIV-1 IIIB-infected MT-4 | Homo sapiens | 1 | ALA1127342 | cell-based format | Scientific Literature | |
| 14. | ALA756512 | B | Inhibitory activity against human aspartyl protease, pepsin at 10 uM | Homo sapiens | 1 | ALA1127342 | single protein format | Scientific Literature | |
| 15. | ALA764928 | B | Binding affinity towards HIV protease | 6 | ALA1129342 | single protein format | Scientific Literature | ||
| 16. | ALA763307 | B | Compound was evaluated for in vitro inhibition of human immunodeficiency virus type 1 (HIV-1) Protease | 8 | ALA1131526 | single protein format | Scientific Literature | ||
| 17. | ALA763873 | B | Tested for inhibition of HIV protease | 15 | ALA1129746 | single protein format | Scientific Literature | ||
| 18. | ALA765638 | B | Tested for the binding affinity against HIV-1 Protease | 1 | ALA1127342 | single protein format | Scientific Literature | ||
| 19. | ALA879230 | B | Tested for the activity against HIV protease | 1 | ALA1127342 | single protein format | Scientific Literature | ||
| 20. | ALA772760 | B | Tested for the binding affinity against HIV-2 Protease | Human immunodeficiency virus 2 | 1 | ALA1127342 | single protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!